Abstract：Objective To analyze the epidemiologic features of hepatitis E in Hunan Province, and to provide evidence for its prevention and control. Method The data of hepatitis E cases in Hunan Province from 2006 to 2014 were collected from the Infectious Diseases Reporting Information System of China Information System of Disease Prevention and Control. The distribution and epidemic characteristics of hepatitis E were analyzed by Excel 2003 and ArcGIS(10.2) softwares. Results A total of 7,124 hepatitis E cases were reported in 2006-2014, with an average annual incidence rate of 1.22/100,000. Overall, the incidence showed an upward trend. The ratio of male cases to females was 2.95:1. The cases distributed among all age groups, with the most cases (25.77%) in the 40-years group. As for occupational distribution, the peasants ranked the first, with 3,858 cases and accounting for 54.15%. With regard to the regional distribution, Huaihua City had the highest incidence, while Loudi City had the lowest. Conclusions The incidence of hepatitis E in Hunan Province in 2006-2014 shows an upward trend. Most of the hepatits E cases are peasants aged ≥40years, and mainly cluster in the northern and western parts of Hunan Province. It is necessary to strengthen the monitoring and comprehensive prevention and control of hepatitis E.
[1] Park SB. Hepatitis E vaccine debuts[J]. Nature, 2012, 491(7422): 21-22. [2] Aggarwal R. Diagnosis of hepatitis E[J].Nat Rev Gastro Hepatol, 2013, 10(1): 24-33. [3] Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E[J].New Eng J Med, 2012, 367(13): 1237-1244. [4] Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E[J]. Lancet, 2012, 379(9835): 2477-2488. [5] Ahmed A, Ali IA, Ghazal H, et al. Mystery of hepatitis e virus: recent advances in its diagnosis and management [J]. Intern J Hepatol, 2015, 2015: 872431. [6] Fujiwara S, Yokokawa Y, Morino K, et al. Chronic hepatitis E: a review of the literature [J]. J Viral Hepat, 2014, 21(2): 78-89. [7] Moal V, Zandotti C,Colson P. Emerging viral diseases in kidney transplant recipients [J]. Rev Med Virol, 2013, 23(1): 50-69. [8] Zhang W, He Y, Wang H, et al. Hepatitis E virus genotype diversity in eastern China [J]. Emerg Infec Dis, 2010, 16(10): 1630-1632. [9] Li SW, Zhao Q, Wu T, et al. The development of a recombinant hepatitis E vaccine HEV 239 [J]. Hum Vacc Immunother, 2015, 11(4): 908-914. [10] 张敏娜, 袁月, 貌盼勇, 等. 中国2004-2013年病毒性肝炎发病与死亡趋势分析[J]. 中华流行病学杂志, 2015, 36(2): 144-147. [11] 欧剑鸣, 谢忠杭, 洪荣涛, 等. 福建省2004-2010年戊型病毒性肝炎流行特征分析[J]. 中华流行病学杂志, 2012, 33(4): 445-446. [12] 秦才珍, 王宏军, 张炜. 姜堰市1999-2010年病毒性肝炎流行特征分析[J]. 实用预防医学, 2011, 18(10): 1882-1884. [13] 李慧梅. 2006-2014年新沂市戊型病毒性肝炎流行病学分析[J]. 现代预防医学, 2015, 42(17): 3100-3102. [14] 穆卫明,张宏. 苏州市甲、戊型病毒性肝炎流行特征对比分析[J]. 实用预防医学, 2003, 10(5): 689-690. [15] Perez-Gracia MT. Hepatitis E: current status [J]. Rev Med Virol, 2013, 23(6): 384-398.
2016, Vol. 23 
